Yanis Tolstov

Head of Medical & Scientific Affairs

Development of the first world diagnostic assay for early detection of aggressive skin cancer (Merkel cell carcinoma). Patented and currently used in patient care. • Certification and management of a Biosafety Level 3 facility, implementation of GLP • Work in regulatory compliance with Biosafety Office managers; development guidelines and SOP for Health Authorities • Implementation of SOPs • Training of personnel • Organization and management of patient Biobank

Led a team of four MBAs on a consulting project focused on market assessment for a new medical device • Performed market research • Identified additional markets (medical, military) • Performed analysis of data and presentation for the CEO • Developed recommendations for senior management (project resulted in future development of the product into the core technology) • Implemented project recommendations resulted in $7.2 Million grant from the US Department of Defense

Product development and marketing projects for newly diagnostic assays (early detection of HIV and HCV infection), Biotech company • Planning of projects, product positioning, interaction with clients • Market research, identification of customer groups, product positioning • Project findings resulted in a federal vaccination program • Data analysis and reports for the projects. • Project reports to senior management and Department of Health officials • International conferences committee member

Optimization of the diagnostics and monitoring of myocardial infarction • Received full PhD scholarship at Yale University School of Medicine • Awarded 1st place prize in Master Thesis competition by the St. Petersburg Naturalists Society • Winner of the Mayor Grant for an outstanding research project among young scientists

Marketing and Strategic Management

Biochemistry and Molecular Biology

Virology